ArticleJournal of clinical microbiology2022
Species Distribution and Antifungal Susceptibilities of
Article in Journal of clinical microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 34 citations in OpenAlex.
- Fatal Fungal Peritonitis Caused by Aspergillus udagawae: An Autopsy Case Report.Internal medicine (Tokyo, Japan) · 2026Article
- Aspergillosis: An Update on Epidemiology, Risk Factors, Diagnosis, Susceptibility, and Treatment.Journal of fungi (Basel, Switzerland) · 2026Review
- Investigation of azole resistance inJournal of medical microbiology · 2026Article
- Global patterns of diversity and distribution in Aspergillus fungi are driven by human and environmental influences.Current biology : CB · 2025Article
- Development and validation of next-generation sequencing-based clinical test for triazole resistance prediction inJournal of clinical microbiology · 2025Article
- Loss of theMicrobiology spectrum · 2025Article
- Adaptation Under Pressure: Resistance and Stress Response Interplay in ClinicalJournal of fungi (Basel, Switzerland) · 2025Article
- Comprehensive Review of Environmental Surveillance for Azole-ResistantJournal of fungi (Basel, Switzerland) · 2025Review
- Molecular identification and antifungal susceptibility testing ofAfrican journal of laboratory medicine · 2025Article
- Trends in the activity of mold-active azole agents againstJournal of clinical microbiology · 2024Article
- Prevalence of Azole-ResistantAntibiotics (Basel, Switzerland) · 2023Article
- Evolution of neuroimaging findings in angioinvasive cerebral aspergillosis in a pediatric patient with leukemia during long-term observation.BMC infectious diseases · 2023Article
- Occurrence of Aspergillus fumigatus azole resistance in soils from Switzerland.Medical mycology · 2023Article
- Epidemiology and antifungal susceptibilities of clinically isolatedEpidemiology and infection · 2023Article
- In Vitro Activity of Isavuconazole and Other Mould-Active Azoles againstJournal of fungi (Basel, Switzerland) · 2023Article
- Species Distribution and Antifungal Susceptibilities ofPathogens (Basel, Switzerland) · 2023Article
- Impact of Infection Patterns on the Outcomes of Patients with Hematological Malignancies in Southwest China: A 10-Year Retrospective Case-Control Study.Infection and drug resistance · 2023Article
- Fungal Nomenclature: Managing Change is the Name of the Game.Open forum infectious diseases · 2023Review
- Dual use of antifungals in medicine and agriculture: How do we help prevent resistance developing in human pathogens?Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy · 2022Article
- New Perspectives on Antimicrobial Agents: Isavuconazole.Antimicrobial agents and chemotherapy · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 1 institution in 2 countries.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.